NGL FINECHEM
Back to All Ratios
|
NGL FINECHEM Last 5 Year EV/CE History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EV/CE(x) | 2.64 | 4.47 | 4.62 | 1.18 | 2.11 |
What is the latest EV/CE ratio of NGL FINECHEM ?
Year | EV/CE |
---|---|
Mar2023 | 2.64 |
Mar2022 | 4.47 |
Mar2021 | 4.62 |
Mar2020 | 1.18 |
Mar2019 | 2.11 |
How is EV/CE of NGL FINECHEM Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2023 | 2.64 | -40.94 | |
Mar2022 | 4.47 | -3.25 | |
Mar2021 | 4.62 | 291.53 | |
Mar2020 | 1.18 | -44.08 | |
Mar2019 | 2.11 | - |
Other Financial Ratios of NGL FINECHEM
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,579.5 Cr | -2.8% | 21.2% | 70.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -2.8% |
21.2% |
70.3% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses